Recruiting
Comparing Rezum and Urolift
About this study
This is a randomized controlled trial using a non-inferiority design with the subjects randomized 1:1 to either water vapour thermal treatment (REZUM) arm or prostatic urethral lift (UroLift) arm.
- Condition
- Prostate Cancer
- Tested
- Rezum, UroLift
- Sponsor
- Chinese University of Hong Kong
Who can join
- Age
- 50 years and older
- Sex
- Male only
- Healthy volunteers
- Not accepted
Inclusion 4
- Minimum age: 50 years
- Eligible sex: Male
- Study condition: Prostate Cancer
- Male ≥ 50 years Symptomatic BPH International prostate symptom score (IPSS) ≥13 Prostate volume 30-80ml
Exclusion 8
- History or high suspicion of prostate cancer
- Current urinary tract infection
- Refractory urinary retention or post-void residual (PVR) ≥250 mL
- Intravesical prostatic protrusion (IPP)\>10mm
- Prior prostate surgery
- Known or suspected allergy to nickel, titanium, or polyester/polypropylene
- Urethral stricture, meatal stenosis, bladder neck contracture
- Neurogenic bladder and/or sphincter abnormalities
Where
1 site, 1 recruiting
Prince of Wales Hospital, The Chinese University of Hong Kong
Hong Kong, Hong Kong
Contact
-
Peter Ka-Fung CHIU
+852 3505 3933 peterchiu@surgery.cuhk.edu.hk
Potential match only. Final eligibility is determined by the study team.